Xenon Pharmaceuticals Inc. (XENE) stock
XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
$38.78−0.48 (-1.22%)
Close on Nov 17, 2026Market cap $3.76BP/E –Yield –
Xenon Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Xenon Pharmaceuticals's total debt was $15.68M at Mar 31, 2020. For fiscal 2019 it was $15.54M, up 3.5% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $15.54M | +3.5% |
| FY2018 | Dec 31, 2018 | $15.01M | +120.7% |
| FY2017 | Dec 31, 2017 | $6.80M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | $15.68M | +3.5% |
| Q4 FY2019 | Dec 31, 2019 | $15.54M | +3.5% |
| Q3 FY2019 | Sep 30, 2019 | $15.40M | +3.5% |
| Q2 FY2019 | Jun 30, 2019 | $15.27M | +30.3% |
| Q1 FY2019 | Mar 31, 2019 | $15.14M | +120.2% |
| Q4 FY2018 | Dec 31, 2018 | $15.01M | +120.7% |
| Q3 FY2018 | Sep 30, 2018 | $14.89M | – |
| Q2 FY2018 | Jun 30, 2018 | $11.72M | – |
| Q1 FY2018 | Mar 31, 2018 | $6.88M | – |
| Q4 FY2017 | Dec 31, 2017 | $6.80M | – |
See a number that looks wrong?